Strategies & Technologies Driving Drug Discovery to Market
Subscribe to Drug Discovery & Development All
View Sample

FREE Email Newsletter

DDD Update

Daily news and top headlines for drug research professionals

Mini-Breast Grown in Petri Dishes: New Tool for Cancer Research

June 15, 2015 8:48 am | by Helmholtz Zentrum Munchen | News | Comments

To elucidate how aggressive types of breast cancer occur, the researchers first examined the function of normal breast stem cells. Read more...


Axial Spondyloarthritis Treatment Market Value Will Almost Double to $2.9B by 2024

June 15, 2015 8:33 am | by Heather Leach, Ph.D., Immunology Analyst, GlobalData | Articles | Comments

The company’s latest report states that the US will cement its position as the largest of the seven major treatment markets (7MM) for axSpA. Read more...


LDC, J&J Innovation to Collaborate on Acceleration of Academic Drug Discovery Initiatives

June 15, 2015 8:22 am | News | Comments

Both companies will collaborate to identify and accelerate innovative drug candidates for the treatment and prevention of diseases with high unmet medical needs. Read more...


Pfizer Reports Top Line Results from Phase 3 Study of Pristiq

June 15, 2015 8:22 am | News | Comments

The drug was evaluated for the efficacy, safety, and tolerability in pediatric patients ages 7 to 17 with Major Depressive Disorder. Read more...


Poisonous Booze Kills Dozens in Nigeria

June 15, 2015 8:21 am | by Seth Augenstein, Digital Reporter | News | Comments

Homemade gin has killed 68 people in less than two weeks in Nigeria, prompting a government crackdown to stop its distillation, according to reports. Read more...


WHO: MERS Not Spreading Outside S. Korea Hospitals

June 15, 2015 8:21 am | by Kim Tong-Hyung, Associated Press | News | Comments

Overcrowded emergency rooms and hospital wards might have contributed to a wider-than-expected transmission of the virus. Read more...


Scientists Identify a Potential New Treatment for Osteoporosis

June 12, 2015 1:57 pm | News | Comments

Scientists from the Florida campus of The Scripps Research Institute (TSRI) have identified a new therapeutic approach that, while still preliminary, could promote the development of new bone-forming cells in patients suffering from bone loss. Read more...


Arcturus, J&J to Collaborate on RNA Medicines

June 12, 2015 1:50 pm | News | Comments

Arcturus Therapeutics, Inc., a leading RNA medicines company, announced today that it has entered into a research collaboration and worldwide license agreement with Janssen Pharmaceuticals, Inc. (Janssen). Read more...


Novartis Gains FDA Approval for ITP Treatment

June 12, 2015 12:51 pm | News | Comments

Novartis announced today that the US Food and Drug Administration (FDA) has approved Promacta (eltrombopag) for the treatment of children six years and older with chronic immune thrombocytopenia (ITP) who have had an insufficient response to corticosteroids, immunoglobulins or splenectomy. Promacta was approved by the FDA in 2008 for use in adult patients with the same condition. Read more...


Petri Dish Tumor Test Could Personalize Drug Therapy for Cancer Patients

June 12, 2015 11:56 am | by University of Wisconsin-Madison | News | Comments

In a highly successful, first-of-its-kind endeavor, a multidisciplinary team of University of Wisconsin-Madison researchers has created a "tumor in a dish:" an ex vivo microenvironment that can accurately anticipate a multiple myeloma patient's response to a drug. Read more...


Drug Discovery Spotlight: FDA Recommendation for Praluent, Repatha; Identifying Past Viral Infections

June 12, 2015 11:29 am | by Stephanie Guzowski, Editor | News | Comments

Two new cholesterol-lowering drugs, in a class their own, were FDA recommended this week and now, await approval. And a reasonably priced, new blood test can reveal a lifetime’s worth of viral infections. Read more...


Statins Don’t Harm Memory After All, Suggests Million-Patient Study

June 12, 2015 10:09 am | by Cynthia Fox, Science Editor | Articles | Comments

Statins, popular cholesterol lowering drugs, do not appear to cause short-term memory loss after all, according to a large recent study in JAMA Internal Medicine. The study, which looked at some one million patients, indicated past memory-loss reports may have been hampered by detection bias, as both statin users and users of non-statin lipid lowering drugs (LLDs) reported some memory loss. Read more...


R&D Deal Heralds New Treatments for Debilitating Conditions

June 12, 2015 9:14 am | by University of Queensland | News | Comments

New treatments are on the horizon for ankylosing spondylitis and two other debilitating conditions that affect up to three per cent of the global population. Read more...


FDA Recommends Approval for GSK's Severe Asthma Drug for Adults

June 12, 2015 9:05 am | News | Comments

The Committee voted against approval of mepolizumab for use in adolescents 12-17 years of age with severe asthma. Read more...


2 South Korean Hospitals Shut Over MERS Fears; 11th Person Dies

June 12, 2015 8:50 am | by Hyung-Jin Kim and Kim Tong-Hyung, Associated Press | News | Comments

South Korean officials believe the disease has peaked and it would begin easing in coming days. Read more...



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.